| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Patel Sanj K | Chairman &CEO | Sell | 136,124 | $25.65 | $3,491,947.24 | -27.2% | -1.5% | +3.2% | |
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 24,248 | $24.79 | $601,107.92 | -55.7% | -1.5% | +3.2% | |
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Paolini John F.51 | Chief Medical Officer | Sell | 22,000 | $26.32 | $578,966.14 | -9.2% | -1.5% | +3.2% | |
| Jul 22, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 3,000 | $0.07 | $210.00 | +0.1% | - | - | |
| Jul 22, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $330.45 | $2,379,244.24 | -24.9% | +11.4% | -10.4% | |
| Jul 19, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 1,873 | $11.13 | $20,846.49 | -0.9% | +3.4% | +31.2% | |
| Jul 18, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 2,743 | $62.00 | $170,066.00 | -0.4% | -2.8% | +8.1% | |
| Jul 18, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $332.74 | $2,395,736.06 | -24.9% | +12.6% | -11.2% | |
| Jul 17, 2024 | ETST Earth Science Tech, Inc. | Tabraue Mario Guillermo | COO | Buy | 10,000 | $0.20 | $2,000.00 | - | - | - | |
| Jul 17, 2024 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 108 | $2.59 | $279.40 | - | -18.7% | -52.7% | |
| Jul 17, 2024 | ESPR Esperion Therapeutics, Inc. | Foody Joanne M.73 | Chief Medical Officer | Sell | 917 | $2.60 | $2,383.28 | -0.3% | -18.7% | -52.7% | |
| Jul 17, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 47,257 | $63.73 | $3,011,592.12 | -2.4% | -7.0% | +8.0% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 2,857 | $150.03 | $428,627.00 | -11.7% | -21.0% | -9.5% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 900 | $150.04 | $135,036.99 | -2.8% | -21.0% | -9.5% | |
| Jul 16, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 472 | $23.23 | $10,964.56 | -13.9% | -11.3% | +124.4% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 900 | $150.04 | $135,036.00 | -4.7% | -21.0% | -9.5% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 930 | $150.03 | $139,530.23 | -0.8% | -21.0% | -9.5% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 7,004 | $150.00 | $1,050,590.19 | -15.0% | -21.0% | -9.5% | |
| Jul 16, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $327.16 | $2,355,544.26 | -29.4% | +8.8% | -9.2% | |
| Jul 16, 2024 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 2,137 | $124.67 | $266,416.92 | -1.7% | -6.4% | -37.1% | |
| Jul 15, 2024 | ETST Earth Science Tech, Inc. | Rose Christopher Alan | CTO | Buy | 22,500 | $0.22 | $4,950.00 | +72.2% | - | - | |
| Jul 15, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 3,000 | $0.07 | $210.00 | +0.1% | - | - | |
| Jul 12, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 9,313 | $22.00 | $204,886.00 | -4.8% | -17.8% | +120.5% | |
| Jul 12, 2024 | TKNO Alpha Teknova, Inc. | Lowell Matthew50 | Chief Financial Officer | Buy | 40,322 | $1.24 | $49,999.28 | +45.8% | +277.3% | +275.8% | |
| Jul 12, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 1,470 | $12.53 | $18,419.10 | -0.7% | -12.5% | +11.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.